DXCM Investor Alert: Robbins LLP Reminds DexCom Inc. Shareholders of Securities Class Action Lawsuit

Robbins LLP reminds investors that a shareholder has filed a class action lawsuit on behalf of all persons and entities that purchased or otherwise acquired DexCom Inc. (NASDAQ: DXCM) securities between January 8, 2024 and July 25, 2024. DexCom is a global company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.

For more information, please submit a form, email attorney Aaron Dumas, Jr., or call us at (800) 350-6003.